Results Snapshot
Quarterly Analysis Highlights - QoQ
Net Sales
QoQ Growth in quarter ended Jun 2026 is 6.57% vs -3.33% in Mar 2026
Consolidate Net Profit
QoQ Growth in quarter ended Jun 2026 is 60.22% vs -25.25% in Mar 2026
Operating Profit (PBDIT) excl Other Income
QoQ Growth in quarter ended Jun 2026 is 5.53% vs -12.32% in Mar 2026
Interest
QoQ Growth in quarter ended Jun 2026 is 26.76% vs 2.82% in Mar 2026
Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Jun 2026 has improved from Mar 2026
Compare Quarterly Results Of Glenmark Pharma With
Quarterly - Net Sales
QoQ Growth in quarter ended Jun 2026 is 6.57% vs -3.33% in Mar 2026
YoY Growth in quarter ended Jun 2026 is 23.10% vs 0.62% in Jun 2025
Quarterly - Consolidate Net Profit
QoQ Growth in quarter ended Jun 2026 is 60.22% vs -25.25% in Mar 2026
YoY Growth in quarter ended Jun 2026 is 930.34% vs -86.23% in Jun 2025
Quarterly - Operating Profit (PBDIT)
QoQ Growth in quarter ended Jun 2026 is 5.53% vs -12.32% in Mar 2026
YoY Growth in quarter ended Jun 2026 is 38.63% vs -1.31% in Jun 2025
Quarterly - Interest
QoQ Growth in quarter ended Jun 2026 is 26.76% vs 2.82% in Mar 2026
YoY Growth in quarter ended Jun 2026 is -7.26% vs 47.12% in Jun 2025
Quarterly - Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Jun 2026 has improved from Mar 2026
YoY Growth in quarter ended Jun 2026 has improved from Jun 2025






